(Q35074187)

6 August 2017

1 reference

title

Orexigenic and anabolic agents (English)

1 reference

6 August 2017

John E Morley

1

1 reference

6 August 2017

1 November 2002

1 reference

Clinics in geriatric medicine

6 August 2017

1 reference

6 August 2017

18

1 reference

6 August 2017

4

1 reference

6 August 2017

853-866

1 reference

Anorexia in older persons: epidemiology and optimal treatment

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Protein-energy oral supplementation in malnourished nursing-home residents. A controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Anorexia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Decreased food intake with aging

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Sarcopenia: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

1 reference

7 January 2021

The cancer anorexia-cachexia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Megestrol acetate in patients with AIDS and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Low dose megestrol acetate can abrogate cachexia in advanced tumor patients receiving systemic interferon-alpha and/or interleukin-2 based antineoplastic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

In re Megestrol acetate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of megestrol acetate and testosterone on body composition in castrated male Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of marihuana on the solution of anagrams, memory and appetite.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Secondary hypogonadism in older men: its relation to impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Predictors of skeletal muscle mass in elderly men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Gonadal dysfunction in systemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of age on testicular function and consequences of testosterone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

1 reference

7 January 2021

Testosterone improves rehabilitation outcomes in ill older men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Editorial: The Role of Androgens in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Oxandrolone restores appetite. An increase in weight helps heal wounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Growth hormone: fountain of youth or death hormone?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Body composition, sex steroids, IGF-1, and bone mineral status in aging men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

What do the serum proteins tell us about our elderly patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Assessment of protein energy malnutrition in older persons, part I: History, examination, body composition, and screening tools

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

The effect of recombinant human growth hormone on malnourished older individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Management of catabolism in metabolically stressed patients: a literature survey about growth hormone application

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Increased mortality associated with growth hormone treatment in critically ill adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

The effect of prostaglandins (PGE2 and PGF2 alpha) on food intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Thalidomide for the treatment of AIDS-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

1 reference

7 January 2021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Anorexia of infection: current prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effect of gastrointestinal peptides on ingestion in old and young mice

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Postprandial cholecystokinin secretion in elderly with protein-energy undernutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Role of CCK in regulation of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Anorexia and aging: pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Relation between postprandial satiation and antral area in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Inhibition of feeding by a nitric oxide synthase inhibitor: effects of aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Prevalence and causes of undernutrition in medical outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Causes of weight loss in a community nursing home

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

1 reference

7 January 2021

Mirtazapine: a review of its use in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

The neuroendocrine control of appetite: the role of the endogenous opiates, cholecystokinin, TRH, gamma-amino-butyric-acid and the diazepam receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly vs. young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

A controlled trial of cisapride in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: relief by cisapride

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Clinical characteristics and six-month outcomes of nursing home residents with low activities of daily living dependency

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Nutritional parameters, body composition, and progression of disability in older disabled residents living in nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Frailty in older adults: evidence for a phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Weight loss and mortality among free-living frail elders: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Anorexia of aging: physiologic and pathologic

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

The anorexia of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Anorexia, sarcopenia, and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Flavor enhancement of food improves dietary intake and nutritional status of elderly nursing home residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Testosterone and frailty

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Andropause: is it time for the geriatrician to treat it?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

Nutritional management in long-term care: development of a clinical guideline. Council for Nutritional Strategies in Long-Term Care

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2802%2900036-8

7 January 2021

10.1016/S0749-0690(02)00036-8

Identifiers

DOI

1 reference

release_slqtvsr42nbz7jlfgu2tjw4vau

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/slqtvsr42nbz7jlfgu2tjw4vau

24 November 2022

mapped directly with Wikidata item

PubMed ID

12608509

1 reference

PubMed ID

12608509